Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
2016 · Nature Communications · 579 citations
https://doi.org/10.1038/ncomms10872
G
Ge Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
987
Papers
29.1K
Citations
82
h-index
475
i10-index
Ge Zhang is an academic researcher. The author has contributed to research in topics: Bone Metabolism and Diseases & Bone health and treatments & Advanced biosensing and bioanalysis techniques. The author has an h-index of 82, co-authored 839 publications.
ORCID: 0000-0002-7807-7695Papers by this author
worksPhase transformation considerations during process development and manufacture of solid oral dosage forms
2004 · Advanced Drug Delivery Reviews · 449 citations
https://doi.org/10.1016/j.addr.2003.10.009
Discovery and development of pyrotinib: A novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancer
2017 · European Journal of Pharmaceutical Sciences · 221 citations
https://doi.org/10.1016/j.ejps.2017.01.021
Targeting loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation
2022 · Nature Communications · 181 citations
https://doi.org/10.1038/s41467-022-31997-8
Therapeutic Potential and Outlook of Alternative Medicine for Osteoporosis
2017 · Current Drug Targets · 165 citations
https://doi.org/10.2174/1389450118666170321105425
SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance
2018 · EBioMedicine · 165 citations
https://doi.org/10.1016/j.ebiom.2018.11.007
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat